The Online Investor
Soliton Inc (SOLY)

Soliton is a medical device company with a proprietary platform technology licensed from The University of Texas MD Anderson Cancer Center. Co.'s rapid acoustic pulse device uses rapid pulses of designed acoustic shockwaves to to disrupt cellular and subcellular structures in the dermis and subcutaneous tissue. Co.'s technology allows a doctor to treat a patient multiple times in a single office visit and reduce the overall time it takes to remove a tattoo.
Company Name: 
Soliton Inc
Medical Instruments & Supplies
Number of ETFs Holding SOLY: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
Quotes delayed 20 minutes

Strong Buy (4.00 out of 4)
82nd percentile
(ranked higher than approx. 82% of all stocks covered)

Analysts' Target Price:
SOLY Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Soliton Inc (SOLY) Page | The Online Investor Page |

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.